PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma von Ansell, Stephen M, Lesokhin, Alexander M, Borrello, Ivan, Halwani, Ahmad, Scott, Emma C, Gutierrez, Martin, Schuster, Stephen J, Millenson, Michael M, Cattry, Deepika, Freeman, Gordon J, Rodig, Scott J, Chapuy, Bjoern, Ligon, Azra H, Zhu, Lili, Grosso, Joseph F, Kim, Su Young, Timmerman, John M, Shipp, Margaret A, Armand, Philippe

Volltext

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study von Lesokhin, Alexander M, Ansell, Stephen M, Armand, Philippe, Scott, Emma C, Halwani, Ahmad, Gutierrez, Martin, Millenson, Michael M, Cohen, Adam D, Schuster, Stephen J, Lebovic, Daniel, Dhodapkar, Madhav, Avigan, David, Chapuy, Bjoern, Ligon, Azra H, Freeman, Gordon J, Rodig, Scott J, Cattry, Deepika, Zhu, Lili, Grosso, Joseph F, Bradley Garelik, M Brigid, Shipp, Margaret A, Borrello, Ivan, Timmerman, John

Volltext

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors von MacFarlane, Alexander W., Jillab, Mowafaq, Smith, Mitchell R., Alpaugh, R. Katherine, Cole, Marion E., Litwin, Samuel, Millenson, Michael M., Al-Saleem, Tahseen, Cohen, Adam D., Campbell, Kerry S.

Volltext

Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network von LACASCE, Ann S, KHO, Michelle E, FRIEDBERG, Jonathan W, NILAND, Joyce C, ABEL, Gregory A, RODRIGUEZ, Maria Alma, CZUCZMAN, Myron S, MILLENSON, Michael M, ZELENETZ, Andrew D, WEEKS, Jane C

Volltext

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma von Leonard, John P., LaCasce, Ann S., Smith, Mitchell R., Noy, Ariela, Chirieac, Lucian R., Rodig, Scott J., Yu, Jian Q., Vallabhajosula, Shankar, Schoder, Heiko, English, Patricia, Neuberg, Donna S., Martin, Peter, Millenson, Michael M., Ely, Scott A., Courtney, Rachel, Shaik, Naveed, Wilner, Keith D., Randolph, Sophia, Van den Abbeele, Annick D., Chen-Kiang, Selina Y., Yap, Jeffrey T., Shapiro, Geoffrey I.

Volltext

Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma von Roberts, John D, Smith, Mitchell R, Feldman, Eric J, Cragg, Louise, Millenson, Michael M, Roboz, Gail J, Honeycutt, Connie, Thune, Rose, Padavic-Shaller, Kristin, Carter, W Hans, Ramakrishnan, Viswanathan, Murgo, Anthony J, Grant, Steven

Volltext

Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma von Shafer, Danielle, Smith, Mitchell R, Borghaei, Hossein, Millenson, Michael M, Li, Tianyu, Litwin, Samuel, Anad, Rachna, Al-Saleem, Tahseen

Volltext

Low Level of Blood CD4+ T-Cells Is An Independent Predictor of Inferior Progression Free Survival in Diffuse Large B-Cell Lymphoma von Judd, Julia, Dulaimi, Essel, Li, Tianyu, Millenson, Michael M, Borghaei, Hossein, Smith, Mitchell R, Al-Saleem, Tahseen

Volltext

Comparison of referring and final pathology for patients with T‐cell lymphoma in the National Comprehensive Cancer Network von Herrera, Alex F., Crosby‐Thompson, Allison, Friedberg, Jonathan W., Abel, Gregory A., Czuczman, Myron S., Gordon, Leo I., Kaminski, Mark S., Millenson, Michael M., Nademanee, Auayporn P., Niland, Joyce C., Rodig, Scott J., Rodriguez, Maria A., Zelenetz, Andrew D., LaCasce, Ann S.

Volltext

Phase I Trial of Multiple Cycles of High-Dose Carboplatin, Paclitaxel, and Topotecan With Peripheral-Blood Stem-Cell Support as Front-Line Therapy von SCHILDER, Russell J, GALLO, James M, ADAMS, Andrea L, CICCOTTO, Suzanne, OZOLS, Robert F, MILLENSON, Michael M, BOOKMAN, Michael A, WEINER, Louis M, ROGATKO, André, ROGERS, Barbara, PADAVIC-SHALLERS, Kristin, BOENTE, Matthew, ROSENBLUM, Norman

Volltext

Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older von Freedman, Gary M., Anderson, Penny R., Goldstein, Lori J., Hanlon, Alexandra L., Cianfrocca, Mary E., Millenson, Michael M., von Mehren, Margaret, Torosian, Michael H., Boraas, Marsha C., Nicolaou, Nicos, Patchefsky, Arthur S., Evers, Kathryn

Volltext

Contribution of Flow Cytometry in the Diagnosis of Cutaneous Lymphoid Lesions von Wu, Hong, Smith, Mitchell, Millenson, Michael M., Nicolaou, Nicos, Van Deerlin, Vivianna M., Addya, Kathkali, Lessin, Stuart, Al-saleem, Tahseen

Volltext

Trimodality Treatment using Integrated Chemoradiation with Surgery for Locally Advanced, Non-small Cell Lung Cancer (LA-NSCLC) von Karur, V, Lally, B, Scott, W, Goldberg, M, Millenson, M, Feigenberg, S, Mosvas, B, Mehra, R, Langer, C

Volltext

Phase I Trial of Multiple Cycles of High-Dose Chemotherapy Supported by Autologous Peripheral-Blood Stem Cells von SCHILDER, R. J, JOHNSON, S, OZOLS, R. F, GALLO, J, KINDSFATHER, S, ROGERS, B, BOOKMAN, M. A, MILLENSON, M. M, BOENTE, M, ROSENBLUM, N, LITWIN, S

Volltext

Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma von Pei, Jianming, Robu, Valentin, Feder, Madelyn, Cheung, Mitchell, Neumann-Domer, Erin, Talarchek, Jacqueline, Dulaimi, Essel, Millenson, Michael M, Testa, Joseph R

Volltext

Pushing the profession: how the news media turned patient safety into a priority von Millenson, M L

Volltext

Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung von Schilder, Russell J, Goldberg, Melvyn, Millenson, Michael M, Movsas, Benjamin, Rogatko, André, Rogers, Barbara, Langer, Corey J

Volltext

Moral Hazard vs. Real Hazard: Quality of Care Post-Arrow von Millenson, Michael L.

Volltext

Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma von Morris, GJ, Millenson, MM, Padavic-Shaller, K, Wang, H, Rogatko, A, Clyde, J, Boyd, RL, Yeslow, G, Halbherr, T, Schilder, RJ, Smith, MR

Volltext

Promising Survival in Patients with Recurrent Non-small Cell Lung Cancer Treated with Docetaxel and Gemcitabine in Combination as Second-Line Therapy von Huang, Chao Hui, Millenson, Michael M., Sherman, Eric J., Borghaei, Hossein, Mintzer, David M., Cohen, Roger B., Staddon, Arthur P., Seldomridge, Judi, Treat, Ocn Joseph, Tuttle, Holly, Ruth, Karen J., Langer, Corey J.

Volltext